Financials
- Market Capitalization 336.28 M
- Employee 35
- Founded 2008
- CEO N/A
- Website www.inhibikase.com
- Headquarter Delaware, United States
- FIGI BBG005TP2339
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-4.18
市销率
53.93
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 3215 | STRO Sutro Biopharma, Inc. - Common Stock | 20.45 USD | -4.04% | +1.34% | -13.27% | +17.60% | 339.08 M USD | ||
| 3218 | ABEO Abeona Therapeutics Inc. - Common Stock | 5.92 USD | -1.99% | -3.43% | -5.43% | -13.45% | 338.53 M USD | ||
| 3260 | IMRX Immuneering Corporation - Class A Common Stock | 4.99 USD | -4.22% | -5.67% | +22.00% | -11.52% | 322.84 M USD | ||
| 3265 | VNDA Vanda Pharmaceuticals Inc. - Common Stock | 5.29 USD | -2.76% | -0.94% | +4.13% | -4.34% | 319.85 M USD |